A Biogen Alzheimer’s drug reduced amyloid plaques and showed a significant slowing of the disease’s hallmark cognitive declines.
A Biogen Alzheimer’s drug reduced amyloid plaques and showed a significant slowing of the disease’s hallmark cognitive declines.